According to reports, the international team of scientists involved in the Moscow State Steel Alloy Institute developed a magnetoprotein injection system, the main core of which is magnetic iron oxide nano-ion, which is enclosed in the outer shell of human ferritin. A large number of experimental data indicate that tumor cells actively "capture" transferrin, a protein responsible for the transport of iron in the blood. When performing magnetic resonance imaging, transferrin enters the target cell lysosome. Magnetoprotein further amplifies the signal.
In conventional magnetic resonance imaging, in order to improve image accuracy, a "contrast agent" is introduced into the human body to make tumor cell imaging more obvious. Even small doses can be dangerous to the human body.
Contrast media (also known as contrast media) is a chemical that is injected (or taken) into human tissues or organs to enhance the effect of imaging. The density of these articles is higher or lower than the surrounding tissue, and the contrast formed is displayed by some instruments. For example, X-ray observation of commonly used iodine preparations, barium sulfate and the like.
After the contrast agent is used, the patient needs to remain intent for at least 30 minutes, as 90% of the side effects occur during this period. High-risk patients should remain inspected for longer periods of time. Delayed responses (skin abnormalities and cardiovascular disorders) can still occur in rare cases. If the symptoms are serious, it should be observed and treated in intensive care.
The magnetoprotein injection system can solve this problem well and improve accuracy.
The “magnetic label†can significantly improve the quality of optical and MRI diagnostics and can also be treated. When a lesion is found, an electromagnetic field or light can affect the accumulation of tumor cells, causing the malignant cells to heat up and die.
Shenzhen Zuomi Technology Co., Ltd. , https://www.bkvis.com